Tandem Diabetes Care (TNDM) Enterprise Value (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Enterprise Value for 14 consecutive years, with $593.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 37.1% year-over-year to $593.4 million; the trailing twelve-month figure through Jun 2026 stood at $593.4 million (down 37.1% YoY), and the FY2025 full-year result was $1.2 billion, down 37.98% from the prior year.
• Enterprise Value eased to $593.4 million in Q2 2026 per TNDM's latest filing, from $743.0 million in the prior quarter.
• Across five years, Enterprise Value topped out at $6.8 billion in Q1 2022 and bottomed at $503.7 million in Q3 2025.
• Historically, Enterprise Value has averaged $1.9 billion across 5 years, with a median of $1.6 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 169.99% in 2024, then sank 78.2% in 2025.
• Over 5 years, Enterprise Value stood at $2.3 billion in 2022, then slumped by 35.56% to $1.5 billion in 2023, then soared by 32.45% to $1.9 billion in 2024, then plunged by 37.98% to $1.2 billion in 2025, then sank by 50.9% to $593.4 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $593.4 million, $743.0 million, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.